基本信息
浏览量:2
职业迁徙
个人简介
Dr. Armand leads the Lymphoma Division at Dana-Farber Cancer Institute. He oversees a diverse portfolio of clinical research across different lymphoma subtypes and types of therapy. Current areas of high priority include:
immunotherapy, especially around the use of engineered cellular therapy (for example chimeric antigen receptor T-cell therapy), immune cell-engaging antibodies, and checkpoint blockade;
the development of personalized targeted therapy, through the application of modern genomic understanding of tumors, the creation of novel assays to characterize individual patients’ genomic profile, and the validation of strategies to match a given tumor profile to a given therapy;
novel therapeutics in T-cell lymphoma, based on a deeper understanding of their molecular underpinnings;
novel therapeutics and novel combinations in CLL, based on integrating clinical data, large-scale and multifaceted laboratory investigations of clinical samples, and clinical trial collaborative structures.
研究兴趣
论文共 454 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
Inhye E. Ahn,Danielle M. Brander,Yue Ren,Yinglu Zhou,Svitlana Tyekucheva, Heather A. Walker, Robert Black,Josie Montegaard,Alvaro Alencar,Leyla Shune,Mohammad Omaira,Caron A. Jacobson,
Blood advancesno. 4 (2024): 832-841
Annals of hematologyno. 1 (2024): 185-198
Austin I Kim,Philippe Armand,Robert A. Redd, Megan Forsyth, Paul Branch,Samantha Pazienza,Lisa Brennan,Victoria Patterson, Susan M Waisgerber,Reid W. Merryman,David C Fisher,Christine E. Ryan,
Blood (2023): 3031
Sally Barrington,Barbara Fischer,Amy A. Kirkwood,Diederik J. Grootendorst, Aytekin Akyol, Steven M. Ansell,Philippe Armand, L. H. Schwartz
Hematological Oncologyno. S2 (2023): 92-93
引用0浏览0引用
0
0
Ayo S Falade,Robert A. Redd,Harsh Shah, Kelsey Baron,Siddharth Iyengar,Sanjal H. Desai, Stephen M Ansell,Ivana Micallef,Adrienne Nedved,Nivetha Ganesan,Tiffany Chang,Gunjan L. Shah,
Blood (2023): 3062
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn